Metformin administration restores allopregnanolone response to adrenocorticotropic hormone (ACTH) stimulation in overweight hyperinsulinemic patients with PCOS-Reference-Cited by-同舟云学术

Metformin administration restores allopregnanolone response to adrenocorticotropic hormone (ACTH) stimulation in overweight hyperinsulinemic patients with PCOS

Published:2010-07-12 Issue:9 Volume:26 Page:684-689
ISSN:0951-3590
Container-title:Gynecological Endocrinology
language:en
Short-container-title:Gynecological Endocrinology

Author:

Genazzani Alessandro D.,Chierchia Elisa,Rattighieri Erika,Santagni Susanna,Casarosa Elena,Luisi Michele,Genazzani Andrea R.

Publisher

Informa UK Limited

Subject

Obstetrics and Gynecology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.tandfonline.com/doi/pdf/10.3109/09513590.2010.500818

Reference52 articles.

1. Circulating Levels of Allopregnanolone in Humans: Gender, Age, and Endocrine Influences

2. Neurosteroids

3. Neurosteroid biosynthesis: genes for adrenal steroidogenic enzymes are expressed in the brain

4. In vivo secretion of 3α-hydroxy-5α-pregnan-20-one, a potent anaesthetic steroid, by the adrenal gland of the rat

5. Neuroactive steroids

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism;International Journal of Molecular Sciences;2022-04-08

2. Neuroendocrine Effects of Carnitines on Reproductive Impairments;International Journal of Molecular Sciences;2021-10-05

3. Polycystic Ovary Syndrome, Affective Symptoms, and Neuroactive Steroids: a Focus on Allopregnanolone;Current Psychiatry Reports;2021-04-21

4. Exploratory study of a screening measure for polycystic ovarian syndrome, quality of life assessment, and neuropsychological evaluation;BMC Women's Health;2020-06-23

5. Differential insulin response to oral glucose tolerance test (OGTT) in overweight/obese polycystic ovary syndrome patients undergoing to myo-inositol (MYO), alpha lipoic acid (ALA), or combination of both;Gynecological Endocrinology;2019-07-13